Readoutin 104d
Seattle Project Corporation — GRT-C901
Phase 3 primary completion: A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer.
- Date
- Mar 2027
- Type
- Readout
- Indication
- Colorectal Neoplasms